Ugurel, O. Et Al. 2020. Evaluation of the potency of FDA-approved drugs on wild type and mutant SARS-CoV-2 helicase (Nsp13). INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES , vol.163 , 1687-1696.

Ugurel, O., Mutlu, Ö., Sariyer, E., Kocer, S., Ugurel, E., Inci, T., ... Ata, O.(2020). Evaluation of the potency of FDA-approved drugs on wild type and mutant SARS-CoV-2 helicase (Nsp13). INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES , vol.163, 1687-1696.

Ugurel, OM Et Al. "Evaluation of the potency of FDA-approved drugs on wild type and mutant SARS-CoV-2 helicase (Nsp13)," INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES , vol.163, 1687-1696, 2020

Ugurel, OM Et Al. "Evaluation of the potency of FDA-approved drugs on wild type and mutant SARS-CoV-2 helicase (Nsp13)." INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES , vol.163, pp.1687-1696, 2020

Ugurel, O. Et Al. (2020) . "Evaluation of the potency of FDA-approved drugs on wild type and mutant SARS-CoV-2 helicase (Nsp13)." INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES , vol.163, pp.1687-1696.

@article{article, author={OM Ugurel Et Al. }, title={Evaluation of the potency of FDA-approved drugs on wild type and mutant SARS-CoV-2 helicase (Nsp13)}, journal={INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES}, year=2020, pages={1687-1696} }